Paper10949029
Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.
Shimomura I and 5 others. Mol Cell, 2000. Cited by 632 papers, by iCite.
Cite this record
ConductScience Library. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Papers, record 10949029. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10949029
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics29
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CCAAT-Enhancer-Binding Proteins | Major topic |
| DNA-Binding Proteins | Major topic |
| Insulin Resistance | Major topic |
| Lipodystrophy | Major topic |
| Liver | Major topic |
| Nuclear Proteins | Major topic |
| Obesity | Major topic |
| Phosphoproteins | Major topic |
| Transcription Factors | Major topic |
| Animals | |
| Base Sequence | |
| DNA Primers | |
| Gene Expression | |
| Glucagon | |
| Humans | |
| In Vitro Techniques | |
| Insulin | |
| Insulin Receptor Substrate Proteins | |
| Intracellular Signaling Peptides and Proteins | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Obese | |
| Mice, Transgenic | |
| Models, Biological | |
| RNA, Messenger | |
| Rats | |
| Rats, Sprague-Dawley | |
| Sterol Regulatory Element Binding Protein 1 |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| HL-20948 | NHLBI NIH HHS | United States | P01HL020948 | PubMed and NIH |
Source NIH RePORTER
Cited by312
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 632 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42820929 | Helios is critical for Treg effector differentiation in adipose autoimmunity. | J Exp Med | 2026 | https://conductscience.org/library/papers/42820929 | PubMed |
| 42509792 | FGF21 and SHBG as Putative Hepatic Axes in Maternal Metabolic Adaptation: A Hypothetical Framework for Postpartum Insulin Sensitivity Restoration. | Biomolecules | 2026 | https://conductscience.org/library/papers/42509792 | PubMed |
| 42241511 | Triglyceride-Rich Lipoprotein Metabolism and Cardiovascular Risk in Diabetes: Bedside to Bench to Bedside. | Circ Res | 2026 | https://conductscience.org/library/papers/42241511 | PubMed |
| 42215843 | Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42215843 | PubMed |
| 42158822 | Insulin increases expression of cannabinoid receptor 1 by suppressing lysosomal degradation via ERK signaling pathway. | Int J Med Sci | 2026 | https://conductscience.org/library/papers/42158822 | PubMed |
| 42063103 | Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progression. | BMC Biotechnol | 2026 | https://conductscience.org/library/papers/42063103 | PubMed |
| 41926189 | The ULK1-NCOA3 axis restrains de novo lipogenesis and prevents diet-induced steatohepatitis and fibrosis in mice. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41926189 | PubMed |
| 41276502 | Fructose and follistatin potentiate acute MASLD during complete hepatic insulin resistance. | Nat Commun | 2025 | https://conductscience.org/library/papers/41276502 | PubMed |
| 41196673 | Molecular mechanisms of metabolic dysfunction-associated steatotic liver disease (MASLD): functional analysis of glucose and fructose metabolism pathways. | Clin Sci (Lond) | 2025 | https://conductscience.org/library/papers/41196673 | PubMed |
| 41010498 | Effects of Diet and Exercise on Mitochondrial Health in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Role of Ceramides. | Nutrients | 2025 | https://conductscience.org/library/papers/41010498 | PubMed |
| 41004573 | Targeted inhibition of hepatic de novo ceramide synthesis ameliorates MASH. | Sci Adv | 2025 | https://conductscience.org/library/papers/41004573 | PubMed |
| 40943477 | Treatment of Dyslipidemia in Patients with Type 1 Diabetes Mellitus: A Review of Current Evidence and Knowledge Gaps. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943477 | PubMed |
| 40868889 | Immune Dysregulation Connecting Type 2 Diabetes and Cardiovascular Complications. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40868889 | PubMed |
| 40521082 | Hepatic Lipidomics Unravels the Lipid-Lowering and Anti-Obesity Efficacy of Diacylglycerol Oil: Mechanistic Insights From High-Fat Diet-Induced Obese Mice. | Food Sci Nutr | 2025 | https://conductscience.org/library/papers/40521082 | PubMed |
| 40444167 | Biochemical, histological, and immunohistochemical study on the therapeutic effects and mechanism of coenzyme Q10 in type 2 diabetes mellitus. | Res Pharm Sci | 2025 | https://conductscience.org/library/papers/40444167 | PubMed |
| 40247011 | Insulin resistance in type 2 diabetes mellitus. | Nat Rev Endocrinol | 2025 | https://conductscience.org/library/papers/40247011 | PubMed |
| 40227546 | Understanding the Link Between Sterol Regulatory Element Binding Protein (SREBPs) and Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD). | Curr Obes Rep | 2025 | https://conductscience.org/library/papers/40227546 | PubMed |
| 40201816 | Canine obesity, overweight, and adipokine serum concentration are associated with hematological, biochemical, hormonal, and cardiovascular markers. | Open Vet J | 2025 | https://conductscience.org/library/papers/40201816 | PubMed |
| 39524330 | High-fat-diet-induced hepatic insulin resistance per se attenuates murine de novo lipogenesis. | iScience | 2024 | https://conductscience.org/library/papers/39524330 | PubMed |
| 39287864 | Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis. | Adv Exp Med Biol | 2024 | https://conductscience.org/library/papers/39287864 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IRS1 | 3667 | PubTator's text mining | https://conductscience.org/library/genes/3667 | NCBI Gene |
| IRS2 | 8660 | PubTator's text mining | https://conductscience.org/library/genes/8660 | NCBI Gene |
| SREBF1 | 6720 | PubTator's text mining | https://conductscience.org/library/genes/6720 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10949029
GET https://conductscience.org/api/papers/v1/10949029/cited_by?page=2